ULBI
Ultralife Corporation · NASDAQ
- Market cap
- $261.2M
Ultralife Corporation (ULBI) is an Industrial Machinery/Components company listed on NASDAQ. In the last 30 days Quantisnow tracked 8 wire items for ULBI, including 4 SEC filings, 2 press releases and news items and 1 earnings update. The most recent was published Nov 12, 2026.
ULBI rankings
Financial highlights
Full financials- Revenue, TTM
- $192.14M
- Revenue growth
- +3.0%
- Net income, TTM
- -$2.96M
- Net margin
- -1.5%
- Free cash flow, TTM
- -$694.0K
- Cash
- $7.63M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks17+100%
2026-05-242026-11-15
Mix890d
- SEC Filings4(50%)
- Other2(25%)
- Earnings1(13%)
- 13D/G1(13%)
Activity · 52 weeks3323 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- 13D/GAmendment: SEC Form SCHEDULE 13D/A filed by Ultralife CorporationSCHEDULE 13D/A - ULTRALIFE CORP (0000875657) (Subject)
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form 10-Q filed by Ultralife Corporation10-Q - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports Third Quarter ResultsNEWARK, N.Y., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the third quarter ended September 30, 2026 with the following results: Sales of $48.3 million compared to $43.4 million for the 2025 third quarterGross profit of $13.3 million, or 27.5% of revenue, compared to $9.6 million, or 22.2% of revenue, for the 2025 third quarterOperating income of $3.2 million compared to an operating loss of $1.0 million for the 2025 third quarterGAAP EPS of $0.14 compared to ($0.07) for the 2025 third quarterAdjusted EBITDA of $5.6 million compared to $2.0 million for the 2025 third quarterBacklog of $136.0 million compared to $117.5 million exitin
- SECSEC Form SC 14D9 filed by Ultralife CorporationSC 14D9 - ULTRALIFE CORP (0000875657) (Subject)
- SECSEC Form 8-K filed by Ultralife Corporation8-K - ULTRALIFE CORP (0000875657) (Filer)
- PREnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense MarketAccelerates EnerSys’ growth in mission-critical defense applications particularly high growth drone and counter drone systems Expands advanced, differentiated battery technologies with U.S.-based manufacturing Increases manufacturing capacity for specialized FEOC-compliant batteries Supports multiple avenues for value creation, including extending EnerSys’ capabilities into new applications within core markets, accelerating growth in existing high-growth areas, and realizing significant cost synergies EnerSys (NYSE:ENS), a global leader in stored energy solutions for industrial, infrastructure, and defense applications, today announced that it has entered into a definitive agre
- PREnerSys to Acquire Ultralife Corporation in a $320 Million All-Cash TransactionNEWARK, N.Y., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) today announced that it has entered into an Agreement and Plan of Merger ("merger agreement") with EnerSys (NYSE:ENS) under which upon closing EnerSys will acquire Ultralife Corporation in an all-cash transaction valued at approximately $320 million, including the assumption of net debt. Under the terms of the merger agreement, which has been unanimously approved by the Boards of Directors of both companies, Ultralife Corporation shareholders will receive $16.00 in cash for each share of Ultralife Corporation common stock they own. The purchase price represents a premium of 166% to Ultralife Corporation’s
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form 10-Q filed by Ultralife Corporation10-Q - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports Second Quarter ResultsNEWARK, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: Sales of $47.9 million compared to $48.6 million for the 2025 second quarterGross profit of $13.9 million, or 28.9% of revenue, compared to $11.6 million, or 23.9% of revenue, for the 2025 second quarter; excluding a $1.1 million net IEEPA refund received in the 2026 second quarter, gross margin was 26.6%Operating income of $3.4 million, including one-time costs of $0.9 million, compared to $2.3 million including one-time costs of $0.3 million for the 2025 second quarterGAAP EPS of $0.15 compared to $0.05 for
- PRUltralife Corporation to Report Second Quarter Results on August 7, 2026NEWARK, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its second quarter results for the period ended June 30, 2026, before the market opens on Friday, August 7, 2026. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:00 AM ET on August 7, 2026. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BI4beea58f157a441ba44284b283b1001f. This w
- SECUltralife Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form DEFA14A filed by Ultralife CorporationDEFA14A - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form DEF 14A filed by Ultralife CorporationDEF 14A - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form SD filed by Ultralife CorporationSD - ULTRALIFE CORP (0000875657) (Filer)
- INSIDERDirector Whitmore Bradford T bought $715,314 worth of shares (108,878 units at $6.57) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERPresident and CEO Manna Michael Edward bought $12,939 worth of Ultralife Common Stock; $.10 par value (2,000 units at $6.47), increasing direct ownership by 7% to 28,674 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- SECSEC Form 10-Q filed by Ultralife Corporation10-Q - ULTRALIFE CORP (0000875657) (Filer)
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports First Quarter ResultsNEWARK, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the first quarter ended March 31, 2026 as follows: Sales of $47.4 million compared to $50.7 million for the 2025 first quarterGross profit of $10.1 million, or 21.3% of revenue, compared to $12.7 million, or 25.1% of revenue, for the 2025 first quarterOperating (loss) of ($.2) million, including one-time costs of $1.7 million, compared to income of $3.4 million for the 2025 first quarterGAAP EPS of ($0.03) compared to $0.11 for the 2025 first quarterAdjusted EBITDA of $3.2 million compared to $5.4 million for the 2025 first quarterBacklog of $115.1 million compared to $110.2 m
- PRUltralife Corporation to Report First Quarter Results on May 8, 2026NEWARK, N.Y., May 01, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 31, 2026 before the market opens on Friday, May 8, 2026. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on May 8, 2026. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BIa05f373879a942b691466d052a5da3ae. This will elim
- SECAmendment: SEC Form 10-K/A filed by Ultralife Corporation10-K/A - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form 10-K filed by Ultralife Corporation10-K - ULTRALIFE CORP (0000875657) (Filer)
- INSIDERDirector Whitmore Bradford T bought $1,196,909 worth of shares (187,512 units at $6.38) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
ULBI FAQ
10 questionsWhat does Ultralife Corporation do?
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company serves government, defense, and commercial sectors. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged...What is the latest news on ULBI?
In the last 30 days Quantisnow tracked 8 wire items for ULBI: 4 SEC filings, 2 press releases and news items, 1 earnings update and 1 13D/G filing. The most recent was published on November 12, 2026.What is ULBI revenue?
Ultralife Corporation (ULBI) reported $192.14M of revenue for the twelve months ended Sep 30, 2026. That is up 3.0% from the year before. Revenue for fiscal 2025 was $191.16M.Is ULBI profitable?
No. Ultralife Corporation reported a net loss of $2.96M for the twelve months ended Sep 30, 2026.How much cash and debt does ULBI have?
Ultralife Corporation reported $7.63M in cash and cash equivalents and $50.52M of debt on its most recent balance sheet in SEC filings.Where does ULBI stock trade?
Ultralife Corporation (ULBI) is listed on NASDAQ.What sector and industry is ULBI in?
Ultralife Corporation operates in the Industrials sector, Industrial Machinery/Components industry.When did Ultralife Corporation go public?
Ultralife Corporation (ULBI) completed its IPO in 1992.What companies are similar to ULBI?
Notable peers in the same industry include JCI (Johnson Controls International plc), LRCX (Lam Research Corporation), ETN (Eaton Corporation PLC), TMO (Thermo Fisher Scientific Inc), ASML (ASML Holding N.V. New York Registry Shares). Compare ULBI side-by-side with any of them on Quantisnow.How can I track ULBI on Quantisnow?
Quantisnow aggregates Ultralife Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ULBI to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change